A Phase 4 interventional study of Diazepam Tablets in Whiplash Injuries and Whiplash Injury of Cervical Spine, sponsored by Edin Mešanović. Completed at 1 site in Bosnia and Herzegovina. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-04.
Sponsored by Edin Mešanović · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Whiplash injury is very common and lot of patients which suffered the injury have chronic symptoms despite different treatment options. One of main symptoms include muscle spasm and pain caused by neck movement. Diazepam is a well known drug which can be used to treat muscle spasms. The aim of this study is to determine whether short term Diazepam therapy can have positive effect on long term outcomes after whiplash injury.
This randomized, assessor-blinded study was conducted on patients presented due to a cervical spine injury caused by a traffic accident in the previous 48 hours from 1st January 2020 to 31st December 2020. All the patient which were included in this study were divided into 2 groups: group A, the Test group, and group B, the control group. All patients signed the consent to participate in the study prior to randomization. During the initial examination a detailed history was taken and it included Visual Analog Pain Scale (VAS). On follow up examinations 7 days, 6 weeks and 6 months after the injury, all patients completed Neck disability index (NDI), Whiplash disability questionnaire (WDQ) as well as Visual Analog Pain Scale (VAS). Any patient which didn't complete all the follow up examination was excluded from the study.
62 studies on the registry are indexed under Whiplash Injuries; 9 are open to participants now.
This study's enrollment of 89 is above the median of 61 across 44 interventional studies indexed under Whiplash Injuries.
Browse Whiplash Injuries studies →Edin Mešanović is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
arm which received Diazepam 5 mg therapy for 7 days after whiplash
Drug: Diazepam Tablets
a group which did not receive Diazepam 5 mg therapy
Diazepam 5 mg tablet once per day (bedtime) for 7 days
change in Whiplash Disability Questionnaire score 6 months after injury (0-130; 0 no disability, 130 maximal disability)
Comparation of same score at the follow up examination 7 days after the injury
Time frame: 6 months
change in Neck Disability Index score 6 months after injury (0-50, 0 - no disability 50 maximal disability)
Comparation of same score at the follow up examination 7 days after the injury
Time frame: 6 months
changes in Visual Analog Scale scores 7 days after the injury (0-10; 0-no pain 10 maximum pain level)
Comparation of same score at the initial examination after the injury
Time frame: 7 days
changes in Visual Analog Scale scores 6 weeks after the injury (0-10; 0-no pain 10 maximum pain level)
Comparation of same score at the initial examination after the injury
Time frame: 6 weeks
changes in Visual Analog Scale scores 6 months after the injury (0-10; 0-no pain 10 maximum pain level)
Comparation of same score at the initial examination after the injury
Time frame: 6 months
change in Whiplash Disability Questionnaire score 6 weeks after injury (0-130; 0 no disability, 130 maximal disability)
Comparation of same score at the follow up examination 7 days after the injury
Time frame: 6 weeks
change in Neck Disability Index score 6 weeks after injury (0-50, 0 - no disability 50 maximal disability)
Comparation of same score at the follow up examination 7 days after the injury
Time frame: 6 weeks
Plan to share: Yes — I am ready to share all IPD that underlie results in a publication
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: I would be ready to share the IPD after publication.
Access criteria: I would like to be included in process of who is getting the IPD.
Ran from Jan 2020 to primary completion in Dec 2020, 11 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Diazepam
Edin Mešanović